Skip to main content

Innovative assay for microRNAs analysis

Project description

An enhanced diagnostic tool identifying numerous diseases will soon be more accessible

DNA and RNA are so well-known they have practically become the topic of cocktail conversation. The new kids on the block are microRNAs (miRNAs). Since their serendipitous discovery in the early 1990s, there are now over 2 000 known miRNAs in humans believed to regulate about a third of the genes in the genome. These small pieces of RNA, about 25 nucleotides in length, regulate critical cellular functions including development, differentiation, growth and metabolism. Conditions as diverse as cancer, liver disease and age-related conditions have all been linked to miRNA function gone awry. LIVELMIA is developing a plan to get its miRNA analysis technology to market. Faster and cheaper diagnostic technology will encourage widespread uptake in clinics and hospitals globally.

Call for proposal

H2020-SMEInst-2018-2020-1
See other projects for this call

Coordinator

BIORIDIS SRL
Address
Via Alfonso Rubbiani 5
40124 Bologna
Italy
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 50 000